Patents by Inventor Stanley R. Bouma

Stanley R. Bouma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6210898
    Abstract: The invention relates to multiplex ligase chain reaction (LCR). Two or more putative target sequences are selected. For each one, a set of four probes is used simultaneously to amplify the putative sequence if it is present in the sample. Preferably, all the amplicons are labeled with a common label/hapten and, for each different target, with a unique label/hapten. The invention also relates to an immunochromatographic strip device and method employing a diagonal array of capture spots.
    Type: Grant
    Filed: September 16, 1999
    Date of Patent: April 3, 2001
    Assignee: Abbott Laboratories
    Inventors: Stanley R. Bouma, Julian Gordon, Joanell Hoijer, Cynthia Jou, James Rhoads
  • Patent number: 6068978
    Abstract: Methods, devices, apparatus and kits for amplifying and detecting nucleic acid are provided. The apparatus is a one or two-tier thermal cycling device that operates in conjunction with a reaction/detection unit. A sample is loaded into a reaction chamber of the device which is then mated with a detection chamber to form the reaction/detection unit. A first heating element of the thermal cycling apparatus applies a desired temperature to the reaction/detection device to amplify target nucleic acid in the sample. The reaction mixture is then transferred to the detection chamber by the second heating element and amplified target nucleic acid is immobilized on a support in the detection chamber. Microprocessor control controls the heat applied by the second element independently of the heat applied by the first element. A detection system associated with the apparatus detects and analyzes the immobilized amplified nucleic acid target.
    Type: Grant
    Filed: May 20, 1997
    Date of Patent: May 30, 2000
    Assignee: Abbott Laboratories
    Inventors: Peter Zaun, Stanley R. Bouma, Julian Gordon, John J. Kotlarik, Natalie A. Solomon
  • Patent number: 5955268
    Abstract: Provided herein are methods for detecting multiple target nucleic acid sequences in a test sample. Also provided is a hybridization platform useful for detecting multiple target sequences in a test sample. The hybridization platform comprises a solid support material having a defined pattern of capture probes immobilized thereon.
    Type: Grant
    Filed: April 26, 1996
    Date of Patent: September 21, 1999
    Assignee: Abbott Laboratories
    Inventors: Edward N. Granados, Stanley R. Bouma, John J. Carrino, Natalie A. Solomon
  • Patent number: 5869252
    Abstract: The invention relates to multiplex ligase chain reaction (LCR). Two or more purative target sequences are selected. For each one, a set of four probes is used simultaneously to amplify the putative sequence if it is present in the sample. Preferably, all the amplicons are labeled with a common label/hapten and, for each different target, with a unique label/hapten. The invention also relates to an immunochromatographic strip device and method employing a diagonal array of capture spots.
    Type: Grant
    Filed: December 18, 1996
    Date of Patent: February 9, 1999
    Assignee: Abbott Laboratories
    Inventors: Stanley R. Bouma, Julian Gordon, Joanell Hoijer, Cynthia Jou, James Rhoads
  • Patent number: 5858652
    Abstract: A method and kits for amplifying and detecting target nucleic acid sequences in a sample is disclosed. The method employs primers which have reactive pair members linked to them. The reactive pair members can be attached to a solid phase and/or detected by labeled conjugate.
    Type: Grant
    Filed: October 28, 1994
    Date of Patent: January 12, 1999
    Assignee: Abbott Laboratories
    Inventors: Thomas G. Laffler, Stanley R. Bouma, Uwe Spies
  • Patent number: 5858732
    Abstract: The present invention provides a method of detecting the amount of a target sequence which may be present in a test sample. The method uses an aggregate primer series, which comprises at least two primer sets, in an amplification reaction to detect the relative concentration of a target sequence which may be present in a test sample. The primer sets have different sensitivities and hybridize with sub-target sequences which are different regions of the target sequence. The method generally comprises cycling a test sample suspected of containing a target sequence, an aggregate primer series, and means necessary for performing an amplification reaction; and detecting any amplified sub-target sequences. Based on a qualitative detection of the amplified sub-target sequences generated by individual primer sets, the relative quantity of the target sequence can be determined.
    Type: Grant
    Filed: August 23, 1996
    Date of Patent: January 12, 1999
    Assignee: Abbott Laboratories
    Inventors: Natalie A. Solomon, Stanley R. Bouma
  • Patent number: 5645801
    Abstract: Methods, devices, apparatus and kits for amplifying and detecting nucleic acid are provided. The apparatus is a thermal cycling device that operates in conjunction with a reaction/detection unit. A sample is loaded into a reaction chamber of the device which is then sealably mated with a detection chamber to form a sealed reaction/detection unit that is virtually irreversibly closed. One or more heating elements of the thermal cycling apparatus applies a desired temperature to the reaction/detection device to amplify target nucleic acid in the sample. The reaction mixture is then transferred to the detection chamber and amplified target nucleic acid is immobilized on a support in the detection chamber. A detection system associated with the apparatus detects and analyzes the immobilized amplified nucleic acid target. Kits include the reaction/detection units and reagents for amplification.
    Type: Grant
    Filed: August 18, 1995
    Date of Patent: July 8, 1997
    Assignee: Abbott Laboratories
    Inventors: Stanley R. Bouma, Ronald A. Coules, Julian Gordon, Eric B. Shain, Natalie A. Solomon, Peter Zaun
  • Patent number: 5585242
    Abstract: An apparatus and method for detecting amplified target nucleic acid is provided wherein the presence and concentration of amplified target is determined by total internal reflection over the course of the amplification reaction. A method and apparatus for detecting target nucleic acid is also provided wherein the presence and concentration of target is determined by total internal reflection and coupling of the target to the TIR element by scissile linkage. An improved immunoassay using total internal reflection and differential temperature cycling is further provided.
    Type: Grant
    Filed: August 31, 1995
    Date of Patent: December 17, 1996
    Assignee: Abbott Laboratories
    Inventors: Stanley R. Bouma, Omar S. Khalil, Edward K. Pabich
  • Patent number: 5484699
    Abstract: Short nucleotide sequences of human papilloma virus useful for the determination of the presence and type of human papilloma virus present in a test sample. The sequences provided can be amplified by polymerase chain reaction or ligase chain reaction. The sequences provided also can be hybridized by standard slot-, dot- or replica-blot procedures. Methods and kits also are provided for the detection of human papilloma virus in a test sample and the determination of the type of human papilloma virus present in the test sample.
    Type: Grant
    Filed: September 30, 1994
    Date of Patent: January 16, 1996
    Assignee: Abbott Laboratories
    Inventors: Stanley R. Bouma, Jeffrey L. Joseph, Ronald L. Marshall, Thomas G. Laffler
  • Patent number: 5415839
    Abstract: Methods, devices, apparatus and kits for amplifying and detecting nucleic acid are provided. The apparatus is a two-tier thermal cycling device that operates in conjunction with a reaction/detection unit. A sample is loaded into a reaction chamber of the device which is then mated with a detection chamber to form the reaction detection unit. A first heating element of the thermal cycling apparatus applies a desired temperature to the reaction/detection device to amplify target nucleic acid in the sample. The reaction mixture is then transferred to the detection chamber by the second heating element and amplified target nucleic acid is immobilized on a support in the detection chamber. A detection system associated with the apparatus detects and analyzes the immobilized amplified nucleic acid target.
    Type: Grant
    Filed: October 21, 1993
    Date of Patent: May 16, 1995
    Assignee: Abbott Laboratories
    Inventors: Peter Zaun, Stanley R. Bouma, Julian Gordon, John J. Kotlarik
  • Patent number: 5208350
    Abstract: This invention relates to fluorescent 7-hydroxy coumarin compounds with substitutions in the 4 position having a length greater than one carbon atom. The compounds thus are related to 4-methylumbelliferone (7-hydroxy-4-methyl coumarin, or 4-MU), the detectable label used in the IM.sub.x .RTM. instrument assays (Abbott Laboratories, Abbott Park, Ill.). The substitutions in the 4 position are branched and include functional groups for coupling to biological molecules.
    Type: Grant
    Filed: May 21, 1991
    Date of Patent: May 4, 1993
    Assignee: Abbott Laboratories
    Inventors: Stanley R. Bouma, Joseph E. Celebuski
  • Patent number: 5006473
    Abstract: The electrophoresis method of the present invention employs a media which contains uniformly dispersed liposomes of phospholipid, or combinations of phospholipid and neutral lipid, which contain chromogenic materials or dye precursers. After electrophoresis of a test sample, the liposomes are lysed and the chromogen or dye material released. The chromogen or dye can be any signal producing substance including a chromogenic agent, and enzyme, a fluorogenic agent, or a chemiluminescent agent, but a detectable signal occurs only where the staining material is in close proximity to specific enzymes, effectors, analytes, or other color-inducing agents which have migrated through the gel during electrophoresis.
    Type: Grant
    Filed: August 9, 1988
    Date of Patent: April 9, 1991
    Assignee: Abbott Laboratories
    Inventors: Stanley R. Bouma, Lawrence J. Blecka, Philip Miller